The test, made by LabCorp, can be purchased online or in a store and allows people to self-collect their nasal swabs at home. They can then send their test samples to LabCorp for testing, and results are delivered by phone call, email or online portal. LabCorp didn’t say what the estimated turnaround time for results would be.
The test is for people aged 18 years and older.
“While many home collection kits can be prescribed with a simple online questionnaire, this newly authorized direct-to-consumer collection kit removes that step from the process, allowing anyone to collect their sample and send it to the lab for processing,” said Jeff Shuren, MD, director of the FDA’s Center for Devices and Radiological Health.
Read the FDA’s full news release here.
More articles on supply chain:
American Airlines to offer at-home COVID-19 tests for travelers
How dry ice makers are preparing for COVID-19 vaccine approval
FDA gives emergency approval to first at-home combination COVID-19 + flu test
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.